Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
15,617
-1,437
-8% -$101K ﹤0.01% 1385
2026
Q1
$1.29M Sell
17,054
-1,328
-7% -$106K 0.01% 1159
2025
Q4
$1.45M Sell
18,382
-65
-0.4% -$5K 0.01% 1025
2025
Q3
$1.37M Buy
18,447
+1,180
+7% +$98.5K 0.01% 942
2025
Q2
$1.52M Buy
17,267
+4,468
+35% +$401K 0.01% 788
2025
Q1
$1.23M Buy
12,799
+2,513
+24% +$225K 0.01% 740
2024
Q4
$865K Buy
10,286
+3,254
+46% +$293K 0.01% 832
2024
Q3
$704K Buy
7,032
+1,087
+18% +$102K 0.01% 709
2024
Q2
$529K Buy
+5,945
New +$507K 0.02% 519

Other funds holding ALC

&Partners's ALC Position: Q2 2026 in Review

&Partners reduced its Alcon (ALC) stake by 8.4% in Q2 2026, selling an estimated $101K and leaving 15,617 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

&Partners first reported a position in ALC in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.52M in Q2 2025. 626 funds tracked by Wall St. Rank hold ALC as of Q2 2026.

  • &Partners held 15,617 shares of Alcon worth $1.05M as of Q2 2026.
  • &Partners sold 1,437 Alcon shares in Q2 2026, an estimated $101K.
  • Alcon made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1385 holding.
  • &Partners first reported a position in Alcon in Q2 2024 and has held it in 9 quarters since.
  • &Partners's Alcon position peaked at $1.52M in Q2 2025.
  • 626 funds tracked by Wall St. Rank held Alcon as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.